Related Experiment Videos

Prior clopidogrel use and outcome of acute coronary syndrome

Roy L Soiza, Stephen J Leslie

    International Journal of Cardiology
    |November 4, 2005
    PubMed

    Insights

    Prior clopidogrel use in acute coronary syndrome did not show a definite increased risk, but a trend towards higher major adverse cardiac events was observed. Further research is needed to clarify this association.

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Prior aspirin use is linked to worse outcomes in acute coronary syndrome (ACS).
    • The association between prior clopidogrel use and ACS outcomes remains unclear.
    • This study investigates the risk associated with pre-admission clopidogrel use in ACS patients.

    Discussion:

    • While not statistically significant, a trend towards increased major adverse cardiac events was noted with prior clopidogrel use.
    • The odds ratio for clopidogrel was 1.46 (95% CI 0.62-3.33), suggesting a potential, albeit not definitive, increased risk.
    • Comparison with aspirin (OR 1.09) and no antiplatelet use (OR 0.91) provides context for clopidogrel's impact.

    Key Insights:

    • Prior clopidogrel use in ACS patients did not yield statistically significant adverse outcomes.
    • A trend towards increased risk of major acute coronary events was observed in patients with prior clopidogrel use.
    • The study highlights the need for further investigation into clopidogrel's role in ACS prognosis.

    Outlook:

    • Further research with larger cohorts is warranted to definitively establish the association between prior clopidogrel use and ACS outcomes.
    • Investigating specific patient subgroups and varying dosages may elucidate nuanced risk profiles.
    • Understanding these associations can refine risk stratification and treatment strategies for ACS.
    Abstract

    Related Concept Videos

    Acute Coronary Syndrome III: Diagnostic Studies01:30

    Acute Coronary Syndrome III: Diagnostic Studies

    Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

    Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
    Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
    Acute Coronary Syndrome I: Introduction01:30

    Acute Coronary Syndrome I: Introduction

    Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
    Acute Coronary Syndrome IV: Interprofessional Care01:28

    Acute Coronary Syndrome IV: Interprofessional Care

    IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
    Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

    Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

    The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
    Acute Coronary Syndrome V: Nursing Management01:26

    Acute Coronary Syndrome V: Nursing Management

    Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...